Post Static Cold Storage Normothermic Machine Liver Perfusion

NCT ID: NCT03176433

Last Updated: 2017-06-05

Study Results

Results pending

The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.

Basic Information

Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.

Recruitment Status

UNKNOWN

Clinical Phase

PHASE1/PHASE2

Total Enrollment

30 participants

Study Classification

INTERVENTIONAL

Study Start Date

2017-05-01

Study Completion Date

2018-07-31

Brief Summary

Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.

The aim of this study is to assess the safety and feasibility of a short period of cold storage prior to normothermic machine perfusion in adult liver transplantation.

Detailed Description

Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.

Conditions

See the medical conditions and disease areas that this research is targeting or investigating.

Liver Transplantation

Study Design

Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.

Allocation Method

NON_RANDOMIZED

Intervention Model

SINGLE_GROUP

Primary Study Purpose

TREATMENT

Blinding Strategy

NONE

Interventions

Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.

Normothermic Machine Liver Perfusion

Liver Preservation Method

Intervention Type DEVICE

Eligibility Criteria

Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.

Inclusion Criteria

* Donors over the age of 16 years.
* Liver allografts from donation after brain death (DBD), standard and extended criteria donors. (SCD, ECD) and donation after circulatory death (DCD) donors.
* Liver must be perfused on OrganOx metra perfusion device within 8 hours of in situ cold perfusion.
* The perfusion should last a minimum of 4 hours and maximum of 24 hours.


* Adult patients (18 years or more).
* Active on the waiting list for liver transplantation.
* Able to give informed consent.

Exclusion Criteria

* Living donors.
* Liver being transplanted as part of a multi-organ transplant (eg liver and kidney).
* Liver intended for split transplant.
* Donor age \<16 years
* Liver which investigator is unwilling to recruit to study.
* Any liver in which logistics prevent perfusion on the OrganOx metra perfusion device within 8 hours of in situ cold perfusion.


* Age less than 18 years.
* Acute/fulminant liver failure.
* Transplantation of more than one organ (e.g. liver and kidney).
* Refusal of informed consent.
* Unable to give informed consent.
Minimum Eligible Age

18 Years

Eligible Sex

ALL

Accepts Healthy Volunteers

No

Sponsors

Meet the organizations funding or collaborating on the study and learn about their roles.

University of Oxford

OTHER

Sponsor Role lead

Responsible Party

Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.

Responsibility Role SPONSOR

Principal Investigators

Learn about the lead researchers overseeing the trial and their institutional affiliations.

Peter Friend

Role: PRINCIPAL_INVESTIGATOR

University of Oxford

Locations

Explore where the study is taking place and check the recruitment status at each participating site.

Addenbrooke's Hospital

Cambridge, , United Kingdom

Site Status RECRUITING

King's College Hospital

London, , United Kingdom

Site Status NOT_YET_RECRUITING

Royal Free Hospital

London, , United Kingdom

Site Status RECRUITING

Countries

Review the countries where the study has at least one active or historical site.

United Kingdom

Central Contacts

Reach out to these primary contacts for questions about participation or study logistics.

Carlo DL Ceresa

Role: CONTACT

00447776362098

Facility Contacts

Find local site contact details for specific facilities participating in the trial.

Christopher Watson

Role: primary

Wayel Jassem

Role: primary

Charles Imber

Role: primary

Other Identifiers

Review additional registry numbers or institutional identifiers associated with this trial.

16/LO/2196

Identifier Type: -

Identifier Source: org_study_id

More Related Trials

Additional clinical trials that may be relevant based on similarity analysis.